Beijing Minhai Biotechnology Co., Ltd

This study tested a new polio vaccine in 1,200 healthy infants aged 2 months. The goal was to see if the vaccine is safe and helps the body build defenses against polio. Results showed the vaccine worked well to trigger an immune response.